Ascension Ventures was among the investors in a round for cardiac monitor developer Bardy, which had raised $27.6m as of October.
US-based cardiac monitor developer Bardy Diagnostics secured an undisclosed but “significant” amount of growth financing from investors including Ascension Ventures, a corporate venturing subsidiary of healthcare provider Ascension.
The round included venture capital firm SV Life Sciences Advisers, private equity firm Health Enterprise Partners and Square 1 Bank, a branch of financial services firm Pacific Western Bank.
Although the precise amount received by Bardy in the round was not revealed, a regulatory filing in October 2016 shows it had…
